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Male rats have about two times as many steroid-responsive
vasopressin-immunoreactive
(AVP-ir) neurons in the bed nucleus of the stria terminalis
(BST) as female rats. This sex
difference does not depend on differences
in circulating
hormone levels, since it persists in males and females that are
treated with similar levels of testosterone.
To analyze the
cellular basis of this sex difference,
we compared the effects
of testosterone
and its metabolites
on AVP mRNA expression in the BST of males and females that were gonadectomized at 3 months of age.
When rats received implants of Silastic tubing filled with
testosterone,
males had more cells that were labeled for
AVP mRNA and more labeling per cell than females. When,
in a second experiment,
rats received
implants
of either
empty tubing, or tubing with dihydrotestosterone
(DHT), estradiol (E), or E plus DHT, hardly any labeled cells were found
in rats with empty implants. E treatment
significantly
stimulated AVP mRNA expression
in both sexes, but significantly
more so in males, which had more cells that were labeled
for AVP mRNA and more labeling per cell than females. DHT
treatment by itself did not stimulate AVP mRNA expression,
but when given in combination
with E, it significantly
increased the number of cells over that of animals treated with
E alone. This increase was seen in males only. However, in
both sexes, it increased
the labeling
per cell over that of
animals treated with E only, but more so in males than in
females. These data suggest that in addition to a sex difference in the number of cells that produce
AVP there is
also a sex difference
in estrogen
as well as androgen
responsiveness
in individual
AVP-producing
cells in the BST.
[Key words: vasopressin,
testosterone,
estradiol, dihycirotestosterone,
aromatase,
sexual dimorphism]

In rodents, gonadal hormone levels determine the direction of
sexual differentiation of centrally regulated functions and behaviors presumably by targeting specific neuronal systemsin a
restricted, critical period around birth. Indeed, many structural
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sex differenceshave beenfound in the brain that depend on the
sex differences in gonadal steroid levels during development
(Yahr, 1988; De Vries, 1990; Breedlove, 1992). An example of
sucha systemis the vasopressin-immunoreactive(AVP-ir) projections of the bed nucleusof the stria terminalis (BST) to brain
areassuchas the lateral septum and lateral habenular nucleus.
Theseprojections are about twice asdensein malesasin females
(De Vries et al., 1981; De Vries and Al-Shamma, 1990) and,
correspondingly, the BST in malescontains about two times as
many AVP-ir cells,or cellsthat can be labeledfor AVP mRNA
as the BST in females(Van Leeuwenet al., 1985; Miller et al.,
1989b).The sex differencesin AVP immunostaining of the BST
projections remain present even when malesand femalesare
treated equally with testosterone(De Vries and Al-Shamma,
1990).
Although the development of this sex difference dependson
the presenceof gonadalsteroidsshortly after birth (Wang et al.,
1993) it is unclear specifically which cellular featuresunderlie
the expressionof this difference. In addition to sex differences
in the absolute number of cells that can produce AVP, these
cells may differ in their responsivenessto gonadal hormones.
After gonadectomy, BST cellslosetheir AVP immunoreactivity
and can no longer be labeled for AVP mRNA unlessthe rats
were treated with testosterone(De Vries et al., 1984, 1985; Van
Leeuwen et al., 1985; Miller et al., 1989a, 1992). This effect of
testosteroneappearsto dependon androgenaswell asestrogen
receptor-mediated mechanisms.Estradiol (E)-which is an estrogenic metabolite of testosteronegeneratedby aromatization
(Naftolin et al., 1975)-partially restoresAVP immunostaining
in castrated male rats, while Sa-dihydrotestosterone (DHT)which is an androgenic, nonaromatizable metabolite of testosterone generatedby reduction (Lieberburgand McEwen, 1975)does not by itself restore AVP immunostaining. However, if
DHT is given in combination with E, it enhancesAVP immunostaining(De Vries et al., 1986).Sincemalerats have higher
levels ofaromatase, the enzyme that catalyzesthe aromatization
of testosteroneinto E, as well as higher numbers of androgen
receptors in the BST than female rats (Roselli, 199l), either of
thesedifference might causetestosteroneto stimulate BST cells
more effectively in male than in female rats. To explore the
possibility that sex differences in the effects of testosteroneon
AVP mRNA expressionmay be basedon sex differencesin the
action of its metabolites,we comparedthe effectsof testosterone
and its metabolites E and DHT on AVP mRNA expressionin
the BST of male and female rats.
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and Methods

In the first experiment, seven adult male and six adult female LongEvans rats (80-90 d old) were gonadectomized and implanted with
Silastic tubing (2.5 cm long, 1.5 mm id., 2.4 mm o.d.) filled with
testosterone, which previously yielded plasma testosterone levels of 2.43.6 &ml, which is in the physiological range for males (De Vries et
al., 1984). In the second experiment, adult male and female Long-Evans
rats (80-90 d old) were gonadectomized and divided into four groups
that received either empty implants (controls; seven males and seven
females), or implants with Sol-dihydrotestosterone (DHT; six males and
six females), estradiol (E; six males and eight females), and E plus DHT
(E+DHT; six males and seven females). The dimensions of the Silastic
tubing for E (1 cm long, 1 mm i.d., 2 mm o.d.) previously yielded
plasma levels of 50-90 ne/ml E. which comnletelv suuuressed LH release
in males, while the dim&sions used for DHT (3 cm, 1.5 mm and 2.4
mm o.d.) previously yielded plasma levels of 0.9-l .8 rig/ml DHT, which
fully restored the size of the seminal vesicles in castrated rats (De Vries
et al., 1986).
In both experiments, the animals were decapitated 4 weeks after
receiving the implants. Their brains were removed, frozen on dry ice,
and stored at - 80°C until they were cut in 25 pm sections with a cryostat.
The sections were thaw mounted onto precleaned Superfrost/plus slides
(Fisher), which were stored at -80°C until used. The in situhybridization closely followed a procedure originally developed by Dr. Scott
Young (Young et al., 1986) and modified by Drs. Dan Dorsa and Margaret Miller (Miller et al., 1992). Slides were postfixed in 4% paraformaldehyde for 5 min and rinsed in 0.1 M phosphate-buffered saline (pH
7.4) for 2 min, both at 4°C. The following incubations were done at
room temperature: one rinse in 1.5% triethanolamine (TEA), an incubation in 0.25% acetic anhydride in TEA (pH 8.0) for 10 min, and two
rinses with 0.03 M Na citrate in 0.3 M NaCl (2x SSC), pH 7.0. The
sections were subsequently defatted in a graded ethanol series, 2 min
each in 70%. 95%. and 100% ethanol: 5 min in chloroform: 2 min each
in 100% and 95%‘ethanol, after which the sections were air dried. Each
slide was placed horizontally and after applying 55 ~1 of hybridization
solution, the slides were covered with silanized coverslips and placed
in a humidified incubator for 14 hr at 37°C. For the first experiment,
the hybridization solution contained 0.8 x lo6 dpm of an oligodeoxyribonucleotide antisense probe that contained 48 bases and was complementary to the AVP mRNA sequence coding for amino acids 129144, which are located at the carboxyl end of the glycopeptide region
of the AVP precursor peptide. For the second experiment it contained
1.2 x lo6 dpm of the probe. The probe was labeled at the 3’-end with
‘5S-dATP (New England Nuclear) using terminal deoxynucleotidyl
transferase (Life Technologies Inc.), purified on a Nen-Sorb column
(New England Nuclear), and heat denatured prior to mixing it with the
rest of the hybridization buffer, which contained 50% formamide, 4 x
SSC, 1 x Denhardt’s solution, 2.5 mg/ml yeast tRNA, 10% dextran
sulfate (MW = SOO,OOO),0.3 M NaCl, 10 mM Tris, and 10 mM dithiothreitol. After incubation, the coverslips were removed by submersing the slides in 1 x SSC, and the slides were rinsed 4 x 15 min
in I x SSC at 55°C and 2 x 60 min in 1 x SSC at room temperature.
The sections were then dehydrated through a graded series of 70%, 95%,
and 100% ethanol and air dried. To reduce RNase activity, all solutions
were prepared with sterile Hz0 that had been treated with 0.1% diethylpyrocarbonate and autoclaved, and all glassware was baked at 250°C
for 12 hr. Controls on the specificity included treating the sections with
ribonuclease A (Sigma), which eliminated labeling; hybridizing sections
with a sense probe, which did not produce any labeling; and rinsing the
sections in 75°C and 9O”C, which greatly diminished and eliminated
labeling, respectively.
To locate the probe, the slides were dipped in Kodak NTB-2 track
emulsion (1: 1 with 0.6 M ammonium acetate, pH 3.5) under safelight,
and stored desiccated in light-tight boxes at 4°C. Four weeks later, the
slides were developed with D19 (Kodak; 1: 1 with distilled water) and
fixed with Kodak Rapid Fix, rinsed in distilled water followed by 0.1
M Na acetate,
pH 3.5, lightly counterstained with 0.2% cresyl violet in
0.1 M acetate
buffer, dehydrated with a graded ethanol series followed
by xylene, and coverslipped.
Sections were studied with a Zeiss Axioscope with a Darklite darkfield attachment (MicroVideo Instruments, Inc., Avon, MA). This attachment guides light from a central source via two fiber optic cables,
which are flattened at the end to match the right- and left-hand ends of
the slide. Because the light enters from the side, much of it is contained
in the slide by total reflection and is only dispersed if it encounters silver

grains. This gives a much brighter image of the silver grains than what
can be obtained with a standard dark-field condenser. AVP mRNAlabeled cells were examined in 14 sections through the BST. Labeled
cells were identified in dark-field illuminated slides, and only counted
if bright-field illumination revealed a Nissl-stained cell and if the number of grains was at least four times higher than background. For each
subject and for each side of the brain, the number of AVP mRNAlabeled cells in the section with most labeled cells were used for data
analysis. Grains were counted using dark-field illumination in the section that contained most AVP mRNA-labeled cells. Images of labeled
cells were obtained with the 40 x objective and a CCD72 camera (Dage,
MTI, Michigan City, IN) connected to a QuickCapture frame grabber
board (Data Translation Inc., Marlboro, MA) in a Macintosh IIfx computer, and analyzed using the IMAGE version 1.44 program developed
by Dr. Rasbaud from NIH, Bethesda, MD. The light intensity and
camera setting were kept constant across the sections in order to standardize measurements. Grains were counted by computerized gray-level
thresholdinz (Shiolev et al.. 1989). which determined the number of
pixels representing images ofgrainsin an area representing a circle with
a diameter of 33 pm centered over the cell. The number of pixels was
converted into number of grains using a linear regression curve that
was obtained by correlating number of pixels with number of grains
that were counted individually in 46 cells with grain counts ranging
from 2 to 141. This gave a correlation coefficient of r = 0.99. The in
situ hybridization and the analysis of the sections were done by experimenters that were blind to the identity of the specimens.
The data were analyzed by a two-way analysis of variance (ANOVA)
with sex as a between-subject variable and side of the brain as a repeated
measure for the first experiment, and by a three-way ANOVA with sex
and treatment as between-subject variables and side as a repeated measure for the second experiment. Significant interactions of treatment
and sex were further evaluated using the Newman Keuls post hoc test.

Results
Effects of testosteroneon A VP mRNA in malesand females
After receiving similar implants of testosterone,male rats had
more AVP mRNA-labeled cellsin the BST (Figs. 1,2; ANOVA,
F = 12.43, df = l/l 1, p < 0.01) and more grains per labeled
cell (Fig. 3; ANOVA, F = 6.63, df = l/l 1,p < 0.05) than female
rats. No significant differenceswere found in the labeling between the left and right side of the brain.
Effects of testosteronemetaboliteson A VP mRNA in males
and females
Overall, male rats had more AVP mRNA-labeled cells in the
BST than female rats (ANOVA, F = 16.98, df = l/45, p <
0.0005). In addition, the various hormonal treatments significantly affectedthe number oflabeled cells(ANOVA, F = 114.32,
df = 3145,p < 000 1).Thesetreatment effects,however, differed
for malesand females(Fig. 4; ANOVA, F = 8.43, df = 3/45, p
< 0.0001). The post hoc Newman Keuls test indicated that
E-treated malesandfemaleshad significantlymore AVP mRNAlabeled cells than males and females given empty tubing or
tubing with DHT. E-treated males, however, showed significantly more labeledcells than E-treated females.Furthermore,
if maleswere treated with E+DHT, they showed significantly
more cells than males treated with E only. However, females
treated with E+DHT did not show more cells than females
treated with E only. No significant differenceswere found in the
number of labeled cells between the left and right side of the
brain.
Since treatment with empty tubing or with DHT resulted in
a lossof virtually all labeled cells in malesas well as females,
analysis of the number of grains over cells was done only in
E-treated and E+DHT-treated animals. In these two groups,
male rats showedmore grains per labeled cell in the BST than
females(Fig. 5; ANOVA, F = 14.93, df = l/23, p < 0.001). In
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Figure 1. Photomicrographs of dark-field illuminated sections displaying cells labeled for AVP mRNA (arrows) in the BST of a female (A) and
a male (B) treated with testosterone. The figure also displays labeled cells in the supraoptic nucleus (SON and the suprachiasmatic nucleus (SCN).
Scale bar, 100 Frn.
addition, E+DHT-treated
rats had more grains per cell than
E-treated rats (Figs. 5, 6; ANOVA,
F = 6.46, df = l/23, p <
0.05). Although the E+DHT
treatment seemed to elevate the
grain density specifically in males, the interaction
of sex and
treatment failed to reach significance (ANOVA,
F = 3.82, df =
l/23, p = 0.063). No significant differences were found in the

H Male
E3lFemale

Figure 2. Differences in the number of BST cells labeled for AVP
mRNA in male (solidbars) and female rats (crosshatchedbars; ANOVA,
p < 0.01). Bars indicate means t SEM.

number of grains per cell between the left and right side of the
brain.
In the suprachiasmatic,
supraoptic, and paraventricular
nuclei, the number of labeled cells and the grain density per cell
could not be determined accurately. In the suprachiasmatic
nucleus, counting cells and grains over cells was impossible because

160

n Male
Ix] Female

0
Figure 3. Differences in the number of grains per BST cell labeled for
AVP mRNA in male (solid bars) and female rats (crosshatched bars;
ANOVA, p < 0.05). Bars indicate means ? SEM.
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Figure 4. Differences in the number of BST cells labeled for AVP
mRNA in male (solid bars) and female rats (crosshatched bars) that were
castrated (Control), or castrated and treated with dihydrotestosterone
(DHT), estradiol, or a combination of estradiol and DHT (E+L)HT).
These treatments had different effects in male and female rats (ANOVA,
p < 0.0001). The Greek letters illustrate the results of the Newman
Keuls post hoc test, which indicated that control and DHT-treated
animals had fewer labeled cells than estradiol- or E+DHT-treated
females, which in turn had less cells than estradiol-treated males. E+DHTtreated males had more cells than any other group. Bars indicate means
I SEM.

the density of AVP cellscausedthe grainsgeneratedby different
cells to overlap, while in the paraventricular and supraoptic
nuclei the grain density per cell was too high to be measured
reliably. None of these nuclei, however, showed any notable
differencesamong the different hormonal conditions.
Discussion
If treated with similar amounts of testosterone,male rats show
more AVP-ir cells in the BST and denser AVP-ir projections
from the BST to areas such as the lateral septum and lateral
habenular nucleusthan female rats (De Vries and Al Shamma,
1990).The resultsof the presentstudy show that, under similar
150

1

I Male
El Female

Estradiol

E+DHT

Figure 5. Differences in the number of grains per BST cell labeled for
AVP mRNA in male (solid bars) and female rats (crosshatched bars)
that were treated with estradiol or a combination of estradiol and dihydrotestosterone (E+DHT).

Number

of Grains

Figure 6. Frequency distributions of BST cells according to the density
of their AVP mRNA labeling in female (top) and male rats (bottom)
treated with estradiol (open bars) or estradiol and dihydrotestosterone
(E + DHT, solid bars).

hormonal conditions, malesalso show more BST cells that can
be labeled for AVP mRNA and more labeling per cell than
females.Furthermore, they show that there are sex differences
in the responsivenessof individual BST cells to testosterone
metabolites, in particular to DHT, which if given in combination with E increasedthe number of AVP mRNA-labeled cells
in malesbut not in females.The possibility that sex differences
in hormone metabolismand in the levelsand actions of estrogen
and androgen receptors contribute to these differenceswill be
discussed.
A previous study comparing AVP mRNA labeling in three
intact malesand three intact femaleshad suggestedthat males
have more BST cells that can be labeled for AVP mRNA and
more grains per labeled cell than females have (Miller et al.,
1989b). Since,in males,AVP mRNA labelingof individual BST
cells reacts within a day to a reduction in gonadal hormone
levels (Miller et al., 1992) the sex differencesin AVP mRNA
labelingreported by Miller et al. (1989b) could have beencaused
by sexdifferencesin gonadalhormone levels. The presentstudy,
however, showsthat sex differencesin AVP mRNA labeling of
BST cells remain presenteven if malesand femalesare treated
with similar amounts of testosterone, suggestingthat sex differencesin AVP mRNA labeling in intact animals cannot be
explained merely by differencesin circulating hormones.
Sex differencesin the interaction of gonadal hormones and
AVP cellsin the BST could have contributed to the sex differencesin AVP mRNA labeling observed in the present study.

The Journal

For testosterone, this interaction appears to involve androgen
as well as estrogen receptor-mediated mechanisms. Previously
we had found that, in castrated male rats, E increases the levels
of AVP immunoreactivity,
but not to the same extent as testosterone does. DHT, when given in a dose that restores the
size of the seminal vesicles, does not influence AVP immunoreactivity by itself, but when given in combination with E, it
restores AVP immunoreactivity
to levels reached after testosterone treatment (De Vries et al., 1986). The present study shows
that, in castrated males, the effects of E and DHT on AVP
mRNA expression are similar to their effects on AVP immunoreactivity. When given by itself, E increased the number of
cells that were labeled for AVP mRNA as well as the level of
AVP mRNA labeling per cell, while DHT when given by itself
did not influence either. However, when given in combination
with E, DHT did increase the number of AVP mRNA-labeled
cells. Recently, we have found that local application of DHT in
the brain of castrated rats can moderately elevate AVP mRNA
labeling in the BST, suggesting that central actions of DHT may
depend on its concentration (Brot et al., 1993).
Since testosterone has to be aromatized into E before it can
influence estrogen receptors (Lieberburg and McEwen, 1975;
Naftolin et al., 1975) the higher levels of aromatase found in
the BST of males (Roselli, 199 1) suggest that under similar
testosterone treatment AVP-producing cells in the BST of males
may be exposed to higher levels of E than similar cells in the
BST of females. However, since males had still more AVP
mRNA-labeled cells and more grains per labeled cell than females after receiving similar E treatment, the sex differences in
AVP mRNA labeling cannot be explained merely by sex differences in the conversion of testosterone into E. Rather, more
BST cells in males respond to estrogen stimulation than in females. The slightly higher proportion of labeling per cell in
E-treated males than in E-treated females suggests that there are
also sex differences in estrogen responsiveness of individual
AVP-producing cells.
Even more so than differences in estrogen responsiveness, sex
differences in androgen responsiveness appear to contribute to
sex differences in AVP-producing cells in the BST. When given
in combination with E, DHT increased the number of AVP
mRNA-labeled cells in males but not at all in females. These
sex differences in steroid responsiveness may be based on sex
differences in inputs that are responsive to gonadal hormones.
There are, for example, sex differences in the substance P and
cholecystokinin innervation of the BST, both of which are responsive to testosterone and E (Malsbury and McKay, 1987;
Simerly and Swanson, 1987; Micevych et al., 1988; Oro et al.,
1988). It is unknown, however, whether these inputs influence
AVP production in the BST. Alternatively, sex differences in
steroid responsiveness of AVP-producing cells in the BST may
be based on differences in androgen and estrogen receptors within these cells, since virtually all them are immunoreactive for
androgen and estrogen receptors (Axelson and Van Leeuwen,
1990; Zhou et al., 1993). Although no sex differences have been
found in the number of estrogen receptors in the BST (Brown
et al., 1988, 1992) there are indeed sex differences in the number
of androgen receptors associated with the cell nuclear fraction
of the BST (Roselli, 199 1). Such sex differences in androgen
receptors could explain why DHT acts on AVP mRNA labeling
in males but not in females.
In addition to sex differences in steroid-sensitive neuronal
inputs or in steroid receptors levels, sex differences in the in-

of Neuroscience,

March

1994,

74(3)

1793

teractions of occupied gonadal steroid receptors may contribute
to sex differences in AVP-producing cells in the BST. For example, since androgen enhances BST aromatase levels in males
more than in females (Roselli et al., 1985a,b; Roselli, 1991)
testosterone may enhance its own conversion into E and therefore its actions on AVP mRNA expression in males more than
in females. This particular androgen effect, however, cannot
explain the sex differences in the effects of DHT on AVP mRNA
in E-treated animals, since these animals were exposed to similar
levels of E. Another possibility is that estrogen increases the
responsiveness of individual cells to androgen in males more
than in females. For example, E might prevent the metabolic
inactivation of DHT in the brain (Sodersten, 1980). E might
also increase the effectiveness of androgen receptors of AVPproducing cells by altering the duration of androgen receptor
occupation, as has been observed in the preoptic area of male
rats (Roselli and Fasasi, 1992). It is unknown, however, whether
there are any sex differences in these actions of E. Finally, there
may be sex differences in the interaction of gonadal steroid
receptors and the AVP gene. Since there are no clearly recognizable androgen- and estrogen-responsive elements on the promoter region ofthe AVP gene (Adan and Burbach, 1992; Young,
1992) the nature of this interaction is unclear.
The sex differences found in the present study suggest
that
sexual differentiation of AVP projections of the BST entails a
number of developmental decisions, among which a decision
as to how many BST cells will express AVP and a decision on
the efficacy of the mechanisms that mediate gonadal hormone
effects on AVP gene expression in individual cells. A recent
study suggests that these decisions depend on differences in the
levels of gonadal hormones in the first weeks after birth (Wang
et al., 1993). Interestingly, the latter study indicated that the
decision as to how many cells will express AVP depends largely
on hormonal differences in the second week after birth, whereas
the decision as to how dense the AVP-ir fiber plexus will bewhich may reflect absolute number as well as AVP content of
individual fibers-depends
on hormonal differences in the first
as well as second week after birth. Such a discrepancy can indeed
be explained by sexual differentiation of several cellular features
that together contribute to the sexually dimorphic nature of
AVP-producing cells in the BST.
AVP projections of the BST are probably involved in social
recognition memory, temperature regulation, and aggressive behavior (Pittman et al., 1988; Bluthe et al., 1990; Koolhaas et
al., 1990) and presumably in osmoregulation and reproductive
functions (Epstein et al., 1983; Demotes-Mainard
et al., 1986;
Bamshad et al., 1993). Therefore, studying how steroid hormones influence these projections will help clarify how hormones induce and maintain the sex differences that have been
found in several of these behaviors and functions (Dantzer and
BluthC, 1992; De Vries et al., 1992). The extreme nature of the
sex differences in, and hormonal effects upon, these projections
will undoubtedly help in this pursuit.
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